These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6265124)

  • 1. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of adrenalectomy on the cardiovascular responses to delta 1-tetrahydrocannabinol in rats.
    Li DM; Chung JP
    Clin Exp Pharmacol Physiol; 1978; 5(3):207-13. PubMed ID: 668209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats.
    Kawasaki H; Watanabe S; Oishi R; Ueki S
    Jpn J Pharmacol; 1980 Aug; 30(4):493-502. PubMed ID: 6259394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
    Kawasaki H; Watanabe S; Ueki S
    Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
    Estrada U; Brase DA; Martin BR; Dewey WL
    Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Watanabe K; Yamamoto I; Yoshimura H
    Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and respiratory effects of cannabis in cat and rat.
    Graham JD; Li DM
    Br J Pharmacol; 1973 Sep; 49(1):1-10. PubMed ID: 4787563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.
    Hine B
    Psychopharmacology (Berl); 1985; 87(1):34-8. PubMed ID: 2997827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lack of beta-adrenoceptor involvement in the cardiac action of delta 1-tetrahydrocannabinol in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1980; 7(1):23-9. PubMed ID: 6247111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
    Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
    Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.
    Lake KD; Martin BR; Kunos G; Varga K
    Hypertension; 1997 May; 29(5):1204-10. PubMed ID: 9149688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1981; 73(1):97-8. PubMed ID: 6262850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the dose and development of acute tolerance to the hypothermic effect of THC.
    Uran B; Tulunay FC; Ayhan IH; Ulkü E; Kaymakçalan S
    Pharmacology; 1980; 21(6):391-5. PubMed ID: 6261269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction and cross-tolerance between ethanol and Δ9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors.
    Dar MS
    Behav Brain Res; 2014 Aug; 270():287-94. PubMed ID: 24875771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.
    Kwolek G; Zakrzeska A; Schlicker E; Göthert M; Godlewski G; Malinowska B
    Br J Pharmacol; 2005 Jul; 145(5):567-75. PubMed ID: 15834445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of brain histamine in delta 9-tetrahydrocannabinol tolerance and withdrawal.
    Verberne AJ; Fennessy MR; Lewis SJ; Taylor DA
    Pharmacol Biochem Behav; 1985 Aug; 23(2):153-9. PubMed ID: 2997805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of beta 2-adrenoceptor blockade and circulating adrenaline level for the pressor responses to beta-adrenoceptor blocking drugs in rats.
    Himori N; Ishimori T; Shiratsuchi K; Tsuneda K; Izumi A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):314-9. PubMed ID: 6145104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.